36-2452. Distribution and sale of laetrile; labeling requirements
A. Laetrile may be distributed or sold by any person within this state and no special license or prescription shall be required for the sale or distribution of this nutritional supplement.
B. The label or other device affixed to a container containing laetrile shall:
1. Clearly identify the nutritional supplement contained therein as laetrile or amygdalin and, at the option of the manufacturer, vitamin B-17.
2. Include a statement that the nutritional supplement contained therein has not been approved as a treatment or cure for cancer by the food and drug administration of the United States department of health, education and welfare.
Section: Previous 36-2353 36-2354 36-2355 36-2401 36-2402 36-2403 36-2451 36-2452 36-2453 36-2501 36-2511 36-2512 36-2513 36-2514 36-2515 NextLast modified: October 13, 2016